Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

18.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Selectfluor-based Polonovski Rearrangement Leading to Novel Entities for Synthetic and Medicinal Applications.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Neurotensin receptor 2 agonism attenuates adverse cardiac remodeling in preclinical models.

Science translational medicine·2026
Same author

Structural basis for uracil removal from DNA by human SMUG1.

Nature communications·2026
Same author

Toward a Random Background for Ligand Optimization.

bioRxiv : the preprint server for biology·2026
Same author

Improving AlphaFold2 Performance in Virtual Screens Targeting GPCRs by Enhancing Binding-Site Conformational Sampling.

Journal of chemical information and modeling·2026
Same author

Molecular mechanisms of native ligand selectivity in catecholamine G protein-coupled receptors.

Nature communications·2026

Related Experiment Video

Updated: Feb 24, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K

Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library.

Barbara Männel1, Mariama Jaiteh2, Alexey Zeifman2

  • 1Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander University , Schuhstraße 19, 91052 Erlangen, Germany.

ACS Chemical Biology
|August 29, 2017
PubMed
Summary

Researchers designed new drugs targeting the D2 dopamine receptor (D2R) for neuropsychiatric diseases. Using computational screening, they discovered compounds that selectively activate specific signaling pathways, potentially leading to safer and more effective treatments.

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

7.3K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.4K

Related Experiment Videos

Last Updated: Feb 24, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

7.3K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.4K

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Computational Biology

Background:

  • Functionally selective ligands for G protein-coupled receptors (GPCRs) offer targeted therapeutic benefits by modulating specific intracellular pathways.
  • Functional selectivity at the D2 dopamine receptor (D2R) is a promising strategy for developing safer and more efficacious treatments for neuropsychiatric disorders.

Purpose of the Study:

  • To computationally design and discover novel functionally selective ligands for the D2 dopamine receptor (D2R) using structure-based virtual screening.
  • To identify compounds that exhibit biased signaling, preferring specific intracellular pathways over others.

Main Methods:

  • Structure-based virtual screening of a custom library of approximately 13,000 compounds against a D2R homology model.
  • Molecular docking to identify ligands interacting with both orthosteric and allosteric sites.
  • Synthesis and pharmacological evaluation of top-ranked compounds in G protein and β-arrestin recruitment assays.

Main Results:

  • Sixteen novel partial agonists for the D2R were discovered from the synthesized compounds.
  • A subset of these ligands demonstrated functional selectivity, with compound 4 showing potent β-arrestin recruitment without significant G protein signaling.
  • The study validated the use of virtual screening and tailored libraries for discovering GPCR ligands with specific functional profiles.

Conclusions:

  • Computational design and structure-based virtual screening are effective strategies for discovering functionally selective GPCR ligands.
  • The identified D2R ligands, particularly compound 4, show potential for developing targeted therapies for neuropsychiatric diseases with improved safety and efficacy profiles.
  • Tailoring ligand interactions with both orthosteric and allosteric sites can precisely modulate receptor signaling pathways.